(Q34693042)

4 August 2017

1 reference

title

Medical treatment of cataract. (English)

1 reference

4 August 2017

Jim Morton

2

0 references

author name string

Tze'yo Toh

series ordinal

1

1 reference

4 August 2017

Jim Coxon

series ordinal

3

1 reference

4 August 2017

Mark J Elder

series ordinal

4

1 reference

4 August 2017

publication date

1 September 2007

1 reference

Clinical and Experimental Ophthalmology

4 August 2017

published in

1 reference

4 August 2017

volume

35

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

664-671

1 reference

Efficacy of different intraocular lens materials and optic edge designs in preventing posterior capsular opacification: a meta-analysis.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

National outcomes of cataract extraction. Increased risk of retinal complications associated with Nd:YAG laser capsulotomy. The Cataract Patient Outcomes Research Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Food and nutrient intake and risk of cataract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Vitamin E supplementation and cataract: randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Carnosine: its properties, functions and potential therapeutic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

L-carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Efficacy of N-acetylcarnosine in the treatment of cataracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

N alpha-acetylcarnosine is a prodrug of L-carnosine in ophthalmic application as antioxidant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Characterization of human tissue carnosinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Purification and properties of human serum carnosinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

India-US case-control study of age-related cataracts. India-US Case-Control Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

The role of sunlight in human cataract formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Bendazac lysine inhibition of human lens epithelial cell adhesion to polymethylmethacrylate intraocular lenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Recent studies of aldose reductase enzyme inhibition for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Current progress in clinical trials of aldose reductase inhibitors in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Can cataract be prevented?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Influence of Age, Diabetes, and Cataract on Calcium, Lipid-Calcium, and Protein-Calcium Relationships in Human Lenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Differential influence of proteolysis by calpain 2 and Lp82 on in vitro precipitation of mouse lens crystallins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

The in vitro retardation of porcine cataractogenesis by the calpain inhibitor, SJA6017.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Structure-activity relationship study and drug profile of N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal (SJA6017) as a potent calpain inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Cataract Image Analysis System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Incremental cost-effectiveness of initial cataract surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Cost-utility analysis of cataract surgery in the second eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

Lack of Evidence for Aspirin Use and Prevention of Cataracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2007.01559.X

10.1111/J.1442-9071.2007.01559.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference